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ABSTRACT 
 
Objective: Fear of cancer recurrence, although distinct from distress continues to 
be under-evaluated, captured, or treated when standard distress scales are used 
to assess concerns of cancer survivors. We tested a model assessing the 
association of demographic and clinical factors, illness representations, and 
perceived risk with fear of cancer recurrence in breast cancer survivors. 
Methods: We recruited 117 breast cancer survivors at least one year after 
completing breast cancer treatment from Internet discussion boards for this 
cross-sectional, descriptive, correlational study. Participants completed a survey 
that assessed their level of fear of cancer recurrence as well as their illness 
representations, perceived risk of recurrence, demographic and medical 
characteristics. 
Results: Our model explained 62% of the variance in fear of cancer recurrence. 
Emotional representations (β= .46, p< .01), symptom attribution (β= .21, p< .01), 
timeline (β= .23, p< .01), and consequences (β= .16, p< .03) were significantly 
related to fear of recurrence. By contrast, the majority of clinical and demographic 
variables were not significant contributors to fear of recurrence. 
Conclusions: Upon completion of cancer treatment, survivors with more 
emotional representations of the experience and those who attribute unrelated 
symptoms to their breast cancer have a higher level of fear of recurrence. 
Evaluation of these factors during treatment may help mitigate fear of recurrence 
in the survivorship phase of the breast cancer trajectory. 
 
 
Key Words: Cancer, Oncology, Internet Recruitment, Emotional representations, 
Symptom attribution, Breast cancer survivorship
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BACKGROUND 
There are currently 2.8 million women alive in the United States who have 
survived a breast cancer diagnosis [1]. Breast cancer survivors are in need of 
follow-up care to assess ongoing psychological needs, evaluate latent physical 
effects of treatment, and monitor for breast cancer recurrence [2].  One of the 
greatest concerns of breast cancer survivors is fear of cancer recurrence (FOCR) 
[3-5]. 
FOCR is a universal ongoing concern that women with breast cancer face 
to varying degrees in their survivorship trajectory [6-11]. As early as the 1970’s, 
researchers reported clinical observations of seemingly well-adjusted cancer 
survivors experiencing subclinical issues and distress long after their cancer had 
been treated and deemed in control [13-15]. The concept of FOCR emerged from 
these early studies and has increasingly been identified as different from anxiety, 
depression, posttraumatic stress disorder (PTSD) while also having a negative 
impact on quality of life in survivorship [4, 7, 8, 16-19]. Because it is a distinct 
concept, fear of recurrence is not evaluated, captured, or treated when standard 
distress scales are used to assess cancer survivors’ concerns [8-10, 19-22]. 
Efforts to identify factors associated with higher FOCR in breast cancer 
survivors and other cancer survivors have only been partially successful. In 
general, past studies found that being younger, having children, coming from a 
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lower socioeconomic group and having less education were associated with 
more FOCR [3-5]. However, findings are mixed in regard to other demographic 
and clinical factors such as ethnicity, time since diagnosis and type of treatment. 
Factors such as anxiety, depression, and various triggers were related to FOCR 
in many studies, although the exact relationship and amount of contribution 
differed widely [3,4,19-22].  
Examining illness representations in breast cancer patients may help 
explain which survivors have higher levels of FOCR. Illness representations are 
individuals’ cognitive and emotional interpretations of an illness threat [23-25]. 
Individuals appraise an illness threat in order to determine if it is serious and 
needs attention versus a minor issue that will resolve on its own [23-25]. These 
appraisals determine the development of illness representations and shape 
future responses to illness threats along with dictating health behaviors [23-25].  
Although research on illness representations within oncology has 
produced mixed results, due to different instruments used and endpoints 
assessed [26-29], some evidence indicates that illness representations may 
affect FOCR among cancer survivors [29]. Breast cancer patients with more of an 
emotional representation of their disease had a poorer perception of their overall 
physical and mental health [26]. Furthermore head and neck cancer patients with 
an illness representation of more severe consequences associated with their 
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cancer and who also held stronger emotional representations of their illness had 
greater FOCR [29]. No relationship was found between demographic or objective 
medical factors and patients’ ongoing FOCR. These finding suggests that illness 
representations alone may be a key factor associated with fear of recurrence in 
cancer patients.  
Another factor postulated to contribute to the formation of illness 
representations is survivors’ perceived risk of their cancer recurring [30-31]. 
Perceived risk of breast cancer recurrence is a personal risk judgment (usually 
captured as a numerical number or percent) made about the probability that 
breast cancer will return [30].  Such judgments are a key part of illness 
representations. Whether the patient judges her risk to be high or low, relative to 
actual risk of recurrence, appears related to the degree that she pursues 
behaviors to minimize potential outcomes from an illness threat [7]. To date, in 
spite of possible interactions, little is known about the relationship between risk 
perception and fear of breast cancer recurrence among breast cancer survivors. 
Thus, the purpose of this study was to examine the relationships between breast 
cancer survivors’ illness representations, perceived risk of recurrence, 
demographic and clinical characteristics, and their FOCR. 
Theoretical Framework and Design 
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The Common Sense Model of Illness Representations developed by 
Leventhal and colleagues [23-24] guided our development of a conceptual model 
for this study (see Figure 1). According to the model, breast cancer survivors with 
certain characteristics (e.g. higher anxiety), illness representations (e.g. greater 
emotional representation) and higher perceived risk are likely to experience 
higher levels of FOCR.  
METHODS 
Design and Sample 
 This study used a cross-sectional descriptive correlational design to 
examine the relationships among study variables. We used a web-based survey 
to collect data from survivors recruited from internet-based discussion boards in 
an attempt to locate longer-term breast cancer survivors who may not be 
attending local cancer clinics. Our survey was administered using Qualtrics 
Survey Software®, an online survey platform used widely for Internet 
distribution/collection of data. We recruited women from the following three 
Internet breast cancer discussion boards: 1) Komen for the Cure, 2) Young 
Survival Coalition and 3) Network of Strength. Prior to recruiting subjects the 
IRB at the University of Michigan approved the study and we obtained permission 
from each site to recruit subjects off their discussion boards. 
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Women were eligible to take part in the study if they were diagnosed and 
treated for any stage of breast cancer (Stage 0-IV) at least one year ago. Women 
were excluded if they were currently in treatment for their primary diagnosis of 
breast cancer, or entered the study but did not complete the fear of recurrence 
questionnaire. Patients with advanced disease (i.e. stage IV) were also eligible 
for the study if they reported that they were not in active treatment for new 
disease progression. A priori power analysis using G*power 3.1 [32] indicated 
that a sample of at least 119 participants would be required to detect a relatively 
small effect size (ES=.3; [33]), using 80% power and an α of 0.05.  
Measures 
We used the State Trait Anxiety Inventory-Trait (STAI-T) form Y-2 for 
adults to measure trait anxiety. This scale has been used widely to measure the 
trait of anxiety in many different patient populations [34].  It consists of 20 self-
rating statements on a Likert type scale with 1=almost never to 4 =almost always. 
Nine items of the twenty are reversed scored. This scale has longstanding 
documented test–retest reliability, validity, and internal consistency α=0.90 [43]. 
In the current study the Cronbach alpha coefficient was .92.  
 We used two instruments to measure Illness representations and risk 
perceptions. The first was the Illness Perception Questionnaire-Revised (IPQ-R), 
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a widely used quantitative measure of illness representations [35]. The IPQ-R, 
uses one dichotomous scale and six 5 point Likert type scales ranging from 
strongly disagree to strongly agree wherein scores can range from 0-30. Seven 
domains assess: 1) Timeline - cyclical, acute/chronic how long will the illness last 
and if so will it continue as a sustained issue or be cyclical in nature. 2) Control, 
how much personal and treatment control do they have or not have over the 
outcomes of their illness. 3) Consequences how much did and will this affect their 
current and future life (Personal, Treatment). 4) Emotional representation is an 
assessment of emotional responses, or a measure of the emotional impact 
generated by the illness. 5) Illness identity or how many symptoms are thought to 
be associated with a diagnosis (symptom attribution). 6) Illness cohesion how 
much understanding and a clear picture of the illness. 7) Cause, things they 
believe caused or contributed to the occurrence of their illness. All of these 
components, in different combinations, have been used previously to identify 
persons experiencing more distress or less control over their illness [7, 23-29]. In 
prior research, internal consistency reliabilities of the IRQ-R subscales (scored as 
continuous variables), ranged from α =0.79-0.89 and had adequate validity [35]. 
The internal consistency reliability of the subscales used in this study were α 
=0.72 -0.87.  
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 To measure risk perception we adapted three Likert-scale items previously 
used and validated [36, 37]. The items ask participants 1) how much they feel 
they are in control over the possibility of their breast cancer recurring, 2) how 
likely they feel that other women will have a breast cancer recurrence, and 3) 
how likely they feel that they themselves will have a recurrence. In addition, 
women were asked to estimate their perception of the chance, in the form of a 
numerical percentage (0-100%), which their breast cancer would recur. All four 
items were used as individual stand-alone scales. 
 The Fear of Recurrence Questionnaire (FRQ) is a 22-item instrument 
designed to measure survivors’ fear of recurrence using a 5-point Likert type 
scale that ranges from strongly agree to strongly disagree [8]. Scores are 
summed to give an overall score. Higher scores indicate more fear of recurrence. 
The questionnaire was specifically designed for use with breast cancer survivors 
to measure FOCR. An internal consistency of α=0.92-0.95 with breast cancer 
survivors has been reported [8, 16, 38]. In the current study the Cronbach alpha 
coefficient was 0.90. 
The survey instrument also collected selected demographic and clinical 
information. The demographic information included: 1) age; 2) race; 3) marital 
status; 4) education level; 5) employment status and 6) income level.  Clinical 
information consisted of: 1) time since diagnosis; 2) type and stage of breast 
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cancer at diagnosis; 3) number and type of surgical interventions; 4) if women 
received adjuvant chemotherapy; 5) if women received radiation therapy; 6) if 
women had or were currently on adjuvant estrogen depriving therapy, and 7) the 
presence and effect of co-morbidities.  
Data Collection  
We invited discussion board members to participate in the study through 
posting of the study link and participation of the investigator in ongoing 
discussions. Once a survivor chose to participate in the study she either clicked 
on the link provided or was emailed the link by the PI. Completion time for the 
survey took between 35-60 minutes with the average being around 40 minutes. 
Women who completed the survey were also encouraged, at completion, to invite 
friends and acquaintances to participate in the study in order to create a snowball 
recruitment effect.  
Data Analysis 
Statistical analysis was done using IBM SPSS 22 (formerly SPSS 22). We 
used mean substitution for missing data when the proportion of missing data was 
very small (<.05%) and of a random nature [39]. However, there was 
considerable missing data for participants’ age (57.3%) and as a result mean 
substitution for age was not acceptable. Also participants’ perception of the 
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chance of a cancer recurrence expressed as a numerical percentage, had 
considerable missing data (30%) with women typing in qualitative comments 
about their risk rather than a percent. Because of the considerable amount of 
missing data, age and the numerical percent for perceived risk of cancer 
recurrence were only used to describe sample characteristics and not included in 
model testing. Results were not substantially changed when dummy coding and 
mean substitution was used for other variables.  
 Race was also excluded from model testing because of the uneven data 
distribution in racial categories. Non-Hispanic Whites comprised 95.7% of the 
subjects while the remaining 4.3% of the subjects were distributed among three 
other categories of the variables (African American 1.7%, Native American 1.7% 
other .9%). Dichotomizing the variable into two levels (Non-Hispanic White and 
other) would not have resolved this uneven distribution; therefore, it was only 
used for descriptive statistics [39].  
Model testing was conducted in two steps. First we assessed the 
correlations among the major study variables and FOCR to identify the nature of 
relationships and variable entry into a regression equation.  Second, we used 
hierarchical regression to determine the amount of variance each conceptual 
model factor contributed to predicting FOCR.  
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Results 
Sample Description  
Women (N=178) from three breast cancer Internet discussion boards 
entered the web-based survey and 121 subjects finished the survey (response 
rate of 68%). However, during data cleaning four further cases were excluded 
due to a large amount of missing data. A final sample (N=117) was used for data 
analysis. Most women were between 46-55 years of age, Caucasian (93%), 
resided in the USA (82%), were partnered (74%), had a bachelors or higher 
degree (56%), and were middle to upper class with an average house hold 
income of > $80.000 (48%).  About one-half were employed full time (47%).  
 Most women were diagnosed and treated for their breast cancer within two 
years (M=2.71, range 1-10 years) and reported having had an invasive cancer 
(76%), a mastectomy (68%), adjuvant chemotherapy (79%), and radiation 
therapy (69%). The sample was evenly distributed between those who had one 
(46%) or more surgeries (54%), and those treated with or currently on adjuvant 
estrogen therapy (47%). The majority of women were diagnosed as a stage II or 
higher (60.5%) with ten women (9%) self-disclosing that they had had a breast 
cancer recurrence.   
Relationship among study variables 
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 Prior to model testing we examined the individual correlations between the 
predictor variables (demographic and medical characteristics, illness 
representations, and risk perception) and FOCR (see Table 1).  Only one 
survivor characteristic (trait anxiety) and two medical characteristics  (years since 
treatment, radiation therapy) had significant correlations with FOCR and were 
retained for the regression model. Higher levels of trait anxiety were associated 
with higher levels of FOCR (r=.443, p< .01). Women who were more years away 
from treatment had lower levels of FOCR (r=-.295, p<. 01), as did women who 
received radiation therapy (r=-.300, p<. 01). Types of cancer (carcinoma in situ, 
invasive etc.) along with all other survivor characteristic (Model 1) were not 
significantly correlated with FOCR and therefore were dropped from model 
testing. 
 Fear of recurrence, illness representations and perceived self risk were 
also correlated with each other (see Table 1). Among the components of illness 
representation, higher fear of recurrence was reported only among women who: 
perceived an associated chronic timeline (r=.45, p< .01), cyclical timeline (r=.20, 
p< .05), perceived more overall consequences (r=.51, p< .01), along with both 
personal (r=-.20, p< .05), and treatment consequences (r=-.22, p< .05), attributed 
more symptoms to their breast cancer (r=.452, p<.01), and had more of an 
emotional representation of their breast cancer (r=.627, p<.01). With regard to 
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risk perception, women who perceived that they were at higher risk of developing 
a recurrence also had a greater level of fear of recurrence (r=.314, p<.01). These 
seven illness representation components and perceived risk were therefore 
retained for the standard regression analyses.      
Model Testing 
 We tested our model using standard regression analysis followed by 
hierarchical regression analysis to determine if patient characteristics (years 
since treatment & radiation therapy), trait anxiety (STAI-T), illness 
representations (seven retained components of IPQ-R), and risk perceptions 
predicted levels of FOCR.  Preliminary analyses were conducted to ensure no 
violation of assumptions of normality, linearity, multicollinearity, and 
homoscedasticity.  Only those variables that had a moderately or higher 
significant bivariate correlation (r≥.20) with FOCR (see Table 1) were included in 
the initial regression model.   
The model explained a total of 62% of the variance (F (10, 106)=17.27, p< 
.01) in fear of recurrence (see Table 2).  However, only four of the eleven 
variables, radiation therapy (β=-.14, p<.03), timeline (β=.21, p<.01), emotional 
representations (β=.44, p<.01), and symptom attribution (β=.21, p<.01), had 
significant independent coefficients while the coefficient for consequences 
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(β=.16, p<.07), treatment consequences (β=.15, p<.06) and self risk (β=.13, 
p<.07) approached significance.  
Next we conducted a hierarchical regression analysis using our 
conceptual model (Figure 1) as a guide. All significant variables were entered in 
blocks one representing survivorship characteristics and the second representing 
illness representations. Table 3 indicates that the identified survivorship 
characteristics accounted for 29% of the variance (F (3, 113)=15.49, p<.01) in 
fear of recurrence and all had significant independent coefficients. When illness 
representations were added they accounted for 62% of the variance (F (8, 
105)=11.64, p<.01). However, only one of the three survivorship characteristics, 
radiation (β=-.14, p<.02), retained its significant independent coefficient the other 
two. Of the eight variables representing illness representations only timeline (β= 
.23, p< .01), consequences (β=.16, p<.03), emotional representations (β= .46, 
p<.01) and symptom attribution (β=.21, p<.01) were found to have significant 
independent coefficients in the model. These findings indicate that 
demographic/clinical characteristics may not be as important as the domains of 
illness representations in predicting FOCR. 
Discussion 
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Illness representations appear to account for a significant amount of 
variance in women’s fear of breast cancer recurrence as predicted in our 
conceptual model. Four of the seven main components of illness representations 
in our model (i.e. emotional representations, symptom attribution, consequences, 
and timeline) were found to significantly contribute to FOCR. These findings are 
similar to others [29, 41], who found that cause, control/cure, consequences and 
symptom attribution were related to increased levels of distress in cancer 
survivors.   
Previous studies have not measured emotional representations that, not 
surprisingly, had a significant association with FOCR in this study. Fear that 
cancer may return will likely evoke emotional responses such as feelings of 
depression, anger, anxiousness, and worry [35]. Emotional representations refer 
to how much the current illness generates these increased emotional responses. 
It is likely that women who experience greater emotional upset with their current 
cancer are likely to continue to have increased emotional responses when they 
consider the possibility of cancer recurring in the future.  This finding however, 
may be specific to frequent users of Internet discussion boards alone.  Emerging 
from treatment of breast cancer with a strong emotional representation of the 
cancer experience (i.e., increased upset) may prompt these women to seek 
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support on the Internet. By contrast, women who have less of an emotional 
representation of their disease may be less likely to participate in this activity.  
 A higher timeline score, an indicator that women may feel that their breast 
cancer will last a long time [35], was significantly correlated with an increase in 
FOCR. This suggests that women who think that cancer will be an ongoing issue 
in their lives will have more FOCR. These women have already experienced the 
effects of cancer treatment on their lives and the fear that it may still be lurking 
ready to strike again in the future would certainly be associated with more FOCR.  
  Symptom attribution, or the labeling of any new or old bodily symptoms to 
a past illness, regardless if the symptom is associated with that illness, [35] was 
also a strong predictor of FOCR. This relationship to FOCR suggests that women 
with heightened bodily awareness are more concerned with recurrence. This is a 
double-edged finding. On one hand being vigilant and reporting concerning 
symptoms could contribute to earlier successful treatment of a recurrence. On 
the other hand, it could compel women to seek symptom evaluation from health 
care providers more frequently than needed [7]. 
Being diagnosed with cancer has been reported to have consequences 
that affect a person and their family personally, emotionally, financially, and 
physically [6-7].  Women who have experienced breast cancer treatment already 
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know it disrupted their lives during their initial diagnosis. It was not surprising in 
our sample that the more women felt that their initial diagnosis of cancer caused 
consequences in their lives, the more they would be afraid of their cancer coming 
back to disrupt their lives again. 
Our findings that demographic/clinical characteristics may not be as 
important as other factors in predicting FOCR in breast cancer survivors are 
consistent with previous work [29]. In head and neck cancer patients’ 
demographic and clinical factors were unrelated to FOCR yet emotional 
representations and belief in consequences from having cancer were related [29]. 
Radiation therapy, however, was the one clinical factor that was related to FOCR 
suggesting that women who undergo radiation therapy may have less FOCR at 
the end of treatment. This finding could be a manifestation of the perception that 
more treatment is better at ensuring no disease recurrence or progression in the 
future [8-10]. Radiation therapy is typically only given to patients who undergo a 
lumpectomy, have extensive disease and/or close margins after mastectomy. In 
our sample, with more women at stage II or greater, we may have had an 
unusual proportion of women who underwent mastectomy with radiation therapy. 
Consequently, this result should be viewed with caution. 
 Surprisingly, trait anxiety was not a significant predictor of FOCR. The 
mean trait anxiety score of our sample was no different than the means reported 
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for other cancer groups suggesting that women’s scores in our study were no 
higher than other cancer survivors [40]. Although trait anxiety was correlated with 
fear of recurrence (Table 1), it was not a significant predictor when assessed in 
conjunction with other study variables within the model (Table 2 & 3). This implies 
that inherent personality traits, prior to diagnosis and treatment for breast cancer, 
may not impact on reactions during and after treatment [42] as much as other 
factors such as emotional representations and symptom attribution. 
 The current study has several limitations. This sample was very selective 
and of a homogenous nature with the majority of women being Caucasian, well 
educated and upper middle class.  Self-selection, exclusive recruitment from 
online sites associated with supportive breast cancer networks, and use of 
snowball recruitment may have produced sampling bias in this study. Sample 
bias may have occurred because this sample excludes women who do not 
participate in these activities or do not have access to the Internet. In addition, 
due to the cross-sectional design causation cannot be determined. An 
established theoretical framework, which provided support for our interpretation 
of the data, guided our study but additional longitudinal studies are needed. 
Finally, the amounts of missing data in specific items are likely associated with 
the online data collection methods wherein we did not force a reply from 
participants to continue in the survey. Therefore, the findings from this study 
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preclude generalizing them to other breast cancer populations. This sample may 
have unique characteristics that are not found in the general population of breast 
cancer survivors and are specific to online populations only.  
Clinical Implications 
FOCR is a common concern of breast cancer patients that appears to be 
associated with the development of negative illness representations. Greater 
FOCR was significantly related to several factors such as the development of 
emotional representations at the end of treatment, increased attribution of 
symptoms present prior to diagnosis, or resulting from the diagnosis, a higher self 
perception of risk of recurrence, and a fear of negative consequences. Given 
these results it is essential to offer psychological counseling and support to 
address fears about disease recurring as well as other factors that may heighten 
it. More specifically, clinicians need to normalize women’s fears about recurrence 
and clarify which symptoms are related to cancer from symptoms that are 
unrelated to it at time of diagnosis and at the end of treatment. In addition 
discussions on actual risk of recurrence using words (e.g., unlikely, low risk) 
along with numerical percentages may reassure those women who significantly 
over-estimate their actual risk [29]. Routine assessment of fear/worry about 
recurrence during treatment could help identify a subset of women with 
significant ongoing issues requiring referral to supportive services and in effect 
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mitigate an overly emotional representation of the breast cancer experience. In 
survivorship care assurances of further treatment options should cancer recur, 
may help decrease breast cancer survivors FOCR as well.  
Women who do not receive the information and support that they need to 
manage their fears within the healthcare system may seek other means of 
support by frequenting Internet support sites.  As valuable as the Internet may be 
it can also be a source of misinformation and may even contribute to a higher 
level of fear. Specifically many triggers are found online that could bombard 
frequent users, increasing rather than alleviating their distress [12]. 
Conclusion  
Future research should seek to develop new methods to identify and then 
to intervene with cancer patients, while in treatment and during early survivorship, 
to mitigate the development of distress in survivorship from an amplified level of 
FOCR.  Further research should also investigate if the factors that accounted for 
a significant amount of variance in fear of recurrence in this study are relevant for 
survivors with other types of cancer as well as breast cancer survivors who do 
not participate in online discussion boards/forums. Lastly, a closer examination of 
potential relationships between FOCR, social support, Internet usage, and 
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utilization of resources may shed some light on how clinical practice during 
treatment can be altered to support women as they transition into survivorship.
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Illness Representations 
1. Timeline (acute/chronic/cyclical) 
2. Perceived Control 
3. Perceived Consequences/Severity 
4. Emotional Representations 
5. Symptom Attribution 
6. Perceived Cause 
 
Risk Perceptions 
1. Perceived Risk of Others 
2. Perceived Risk of Self  
Survivor 
Characteristics 
Demographic 
1. Age  
2. Trait Anxiety 
3. Education 
4. Income 
5. Ethnicity 
Clinical 
1. Stage at diagnosis 
2. Treatment Received 
3. Co-morbidities   
 Figure 1:Breast Cancer Survivorship Model of Predictors of Fear of Recurrence 
 Fear 
 of  
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Table 1 
Correlation Matrix for Fear of Cancer Recurrence (FRQ) and Significant Characteristics, Trait Anxiety (STAI-T), Illness 
Perceptions (IPQ-R), and Risk Perceptions (RP1-3) 
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tri
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tio
n 
Se
lf 
R
is
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Fear of Cancer Recurrence 1            
Years since treatment -.29** 1           
Radiation therapy -.30**  .00 1          
Trait Anxiety  .44** -.13 -.16 1         
Timeline  .45** -.22* -.03  .27** 1        
Time Cyclical  .20* -.08 -.15  .04  .32** 1       
Consequences  .51** -.32** -.09  .27**  .34**  .17 1      
Personal Consequences -.20*  .03  .01 -.35** -.33** -.12 -.10 1     
Treatment Consequences -.22*  .05  .02 -.22* -.54** -.23** -.22*  .47** 1    
Emotional Representations  .62** -.16 -.18  .57**  .22*  .25**  .43** -.25** -.19* 1   
Symptom Attribution  .35** -.26* -.29**  .27**  .29**  .19*  .24** -.16 -.25** .20* 1  
Self Risk  .31** -.18 -.05  .11  .53**  .13  .25** -.27** -.40** .04 .28** 1 
**. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 0.05 level (2-tailed). 
 
This article is protected by copyright. All rights reserved.
Illness representations, risk perception and fear of cancer recurrence 
 
 
 
Table 2 
Summary of Standard Multiple Regression of all significant predictors for Fear of Recurrence (FRQ)(N=117)  
Variable      B   SE    β     t    P 
Years since Treatment -.22 .37 -.04 -.59 .56 
Radiation -2.09 .97 -.14 -2.17 .03 
Trait Anxiety .05 .10 .04 .52 .60 
Time Line .51 .20 .21 2.55 .03 
Time Cyclical  
Consequences 
-.32 
.53 
.27 
.24 
-.07 
.16 
-1.15 
2.17 
.25 
.07 
Personal Consequences -.01 .21 -.01 -.06 .95 
Treatment Consequences .65 .33 .15 1.87 .06 
Emotional 
Representations 
1.23 .22 .44 5.53 .01 
Symptom Attribution .71 .24 .21 2.93 .01 
Self Risk .82 .47 .13 1.73 .07 
      
Linear regression of all variables with significant correlations at the 0.05 level, R2 = .620 (62%); constant =16.7 
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Table 3 
Summary of Hierarchical Regression Analysis for variables predicting Fear of 
Recurrence (FRQ)(N=117) 
 Model 1 Model 2 
Variable B SE B β B SE B β 
Years since 
Treatment 
 
 
-1.23 .46 -.21** -.22 .37 -.04 
Radiation Therapy -3.56 1.2 -.23** -2.2 .97 -.14* 
Trait Anxiety .51 .11 .38** .03 .11 .02 
Timeline    .56 .21 .23** 
Time Cyclical    -.32 .28 -.08 
Consequences    .52 .24 .16* 
Personal 
Consequences    -.02 .21 -.01 
Treatment 
Consequences    .63 .35 .14 
Emotional 
Representations    1.30 .23 .46** 
Symptom 
Attribution    .73 .24 .21** 
Self Risk    .79 .47 .12 
R2  .29   .62  
F for change in R2 15.49**  11.64**  
*p < .05. **p < .01. 
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